As we age, the muscles we rely on for daily activities tend to become less reliable. With enough decline, even normal movements such as getting out of bed become risky. Low muscle mass in the ...

As the first and only PD-L1 immune checkpoint inhibitor approved for aCSCC, UNLOXCYT is an evolution in checkpoint inhibition, offering a balance of durable clinical responses and acceptable ...

MUMBAI, India and PRINCETON, N.J., Nov. 25, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE ...

Blue Label has achieved majority ownership of Cell C. Blue Label has finally achieved its almost decade-long goal of securing a majority stake in Cell C, South Africa’s fourth biggest mobile operator, ...

Unichem Pharmaceuticals has recalled one lot of a muscle relaxer because the pills in the bottle might not be the muscle relaxer on the label. The East Brunswick, New Jersey, company’s FDA-posted ...

Blue Label Telecoms co-CEOs Mark and Brett Levy. JSE-listed Blue Label Telecoms is reaping financial benefit from its investment in Cell C, as its headline earnings per share (HEPS) shot up in the ...

Aging is an independent risk factor for cardiovascular disease. Preventing age-induced arterial dysfunction and the associated risk of cardiovascular disease remains a significant clinical challenge.

Scientists in Tokyo have developed a groundbreaking, label-free method to identify aging human cells using electric fields. This new technique avoids the downsides of chemical tagging, which can ...

Biohybrid robots work by combining biological components like muscles, plant material, and even fungi with non-biological materials. While we are pretty good at making the non-biological parts work, ...

Our biceps and our brain cells may have more in common than previously thought. New research led by the Lippincott-Schwartz Lab shows that a network of subcellular structures similar to those ...

A muscle patch crafted from stem cells has improved cardiac function in monkeys with heart disease. It is now being tested in a small number of people, with early results from the first recipient ...